Azenta, Inc. (AZTA) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $24.26. It has a SharesGrow Score of 46/100, indicating a mixed investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of AZTA = $69.76 (+187.6% from the current price, the stock appears undervalued). Analyst consensus target is AZTA = $43 (+77.2% upside).
Valuation: AZTA trades at a trailing Price-to-Earnings (P/E) of -17.3 (S&P 500 average ~25).
Financials: revenue is $594M, +3%/yr average growth. Net income is $56M (loss), growing at -337.3%/yr. Net profit margin is -9.4% (negative). Gross margin is 45.5% (-0.5 pp trend).
Balance sheet: total debt is $111M against $1.7B equity (Debt-to-Equity (D/E) ratio 0.06, conservative). Current ratio is 2.98 (strong liquidity). Debt-to-assets is 5.4%. Total assets: $2.1B.
Analyst outlook: 7 / 12 analysts rate AZTA as buy (58%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 60/100 (Pass), Growth 30/100 (Fail), Past 0/100 (Fail), Health 100/100 (Pass), Moat 59/100 (Partial), Future 64/100 (Pass), Income 10/100 (Fail).
